#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Focal segmental glomerulosclerosis PIK3CA related overgrowth spectrum Myeloid leukaemia Spina bifida Sexually transmitted disease Pyruvate kinase deficiency anaemia Allogenic stem cell transplantation Phaeochromocytoma B-cell lymphoma Univentricular heart Lymphatic malformation Marginal zone lymphoma Thrombocytopenia Transferrin decreased Haemophilia A without inhibitors More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Life with Disease Gaucher’s disease type III – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Burkitt’s lymphoma – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Atypical haemolytic uraemic syndrome – Basic Information Stevens-Johnson syndrome – Treatment Netherton’s syndrome – Life with Disease Niemann-Pick disease – Life with Disease Langerhans cell sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Navtemadlin Hydroxi-Methionine Calcium Human Coagulation Factor X Avacincaptad Pegol Levoleucovorin Disodium HALOBETASOL PROPIONATE JNJ-75276617 Nvdx3 Difelikefalin L-Arginine Hydrochloride Mebendazole Gd2Il18Cart ELTANEXOR Propafenone Hydrochloride Eteplirsen Reparixin Sodium Glycerophosphate Azenosertib Ibuprofen Riliprubart More therapies…

    Learn about Your Condition

    Hyperkalaemia Eyelid ptosis Spinal cord injury Vascular calcification Carotid artery occlusion Adrenogenital syndrome Embolism venous Cardiogenic shock Laryngeal cancer stage I Viral myocarditis Pain Breast conserving surgery Spermatocele Genital herpes Round cell liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Bempedoic acid in drug combination for patients with coronary artery disease without prior cardiovascular events

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    Investigated Drugs:
    • Bempedoic Acid
    • Ezetimibe
    • Atorvastatin
    Germany Italy Spain

  • Open‑Label Extension Study of Avutometinib Alone or with Defactinib in Patients with Recurrent Low‑Grade Serous Ovarian Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Avutometinib
    • Defactinib
    France

  • Efficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee

    Recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Denmark

  • Safety and Tolerability of Intrathecal TRCN-1023 in Adults with Amyotrophic Lateral Sclerosis (ALS) – Randomized Placebo‑Controlled Phase 1/2 Trial

    Recruiting

    1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Germany The Netherlands

  • A Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    France Germany Greece Italy The Netherlands Poland

  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +15
Previous Page
1 2 3 4 5 6 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!